Trial Profile
Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2011
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin aspart
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 05 Nov 2010 New trial record.